Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$12.1 - $19.54 $53,361 - $86,171
-4,410 Reduced 13.74%
27,690 $335,000
Q1 2024

May 10, 2024

SELL
$20.51 - $26.65 $172,858 - $224,606
-8,428 Reduced 20.8%
32,100 $696,000
Q4 2023

Feb 02, 2024

SELL
$19.94 - $26.64 $171,962 - $229,743
-8,624 Reduced 17.55%
40,528 $1.06 Million
Q3 2023

Nov 03, 2023

SELL
$20.9 - $30.85 $204,402 - $301,713
-9,780 Reduced 16.6%
49,152 $1.09 Million
Q2 2023

Aug 14, 2023

SELL
$28.37 - $36.31 $33,873 - $43,354
-1,194 Reduced 1.99%
58,932 $1.68 Million
Q1 2023

May 03, 2023

BUY
$32.33 - $37.71 $31,521 - $36,767
975 Added 1.65%
60,126 $2.08 Million
Q4 2022

Feb 10, 2023

BUY
$30.52 - $41.79 $37,234 - $50,983
1,220 Added 2.11%
59,151 $2.21 Million
Q3 2022

Nov 14, 2022

SELL
$31.4 - $42.04 $66,944 - $89,629
-2,132 Reduced 3.55%
57,931 $1.82 Million
Q2 2022

Aug 08, 2022

SELL
$37.9 - $46.81 $133,332 - $164,677
-3,518 Reduced 5.53%
60,063 $2.28 Million
Q1 2022

May 12, 2022

SELL
$44.77 - $54.33 $38,009 - $46,126
-849 Reduced 1.32%
63,581 $2.85 Million
Q4 2021

Feb 10, 2022

SELL
$43.72 - $52.25 $20,679 - $24,714
-473 Reduced 0.73%
64,430 $3.36 Million
Q3 2021

Nov 15, 2021

SELL
$45.58 - $51.78 $164,088 - $186,408
-3,600 Reduced 5.26%
64,903 $3.05 Million
Q2 2021

Aug 06, 2021

SELL
$50.84 - $56.8 $121,965 - $136,263
-2,399 Reduced 3.38%
68,503 $3.6 Million
Q1 2021

May 11, 2021

SELL
$41.16 - $55.05 $49,391 - $66,060
-1,200 Reduced 1.66%
70,902 $3.89 Million
Q4 2020

Feb 02, 2021

SELL
$33.52 - $44.1 $108,437 - $142,663
-3,235 Reduced 4.29%
72,102 $2.88 Million
Q3 2020

Nov 12, 2020

SELL
$34.67 - $43.16 $144,261 - $179,588
-4,161 Reduced 5.23%
75,337 $2.71 Million
Q2 2020

Aug 13, 2020

SELL
$38.35 - $47.02 $166,860 - $204,584
-4,351 Reduced 5.19%
79,498 $3.37 Million
Q1 2020

May 26, 2020

BUY
$41.02 - $59.59 $3.44 Million - $5 Million
83,849 New
83,849 $3.84 Million
Q1 2020

May 15, 2020

SELL
$41.02 - $59.59 $3.67 Million - $5.33 Million
-89,447 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$52.08 - $62.72 $425,649 - $512,610
-8,173 Reduced 8.37%
89,447 $5.27 Million
Q3 2019

Nov 14, 2019

SELL
$49.29 - $58.06 $112,134 - $132,086
-2,275 Reduced 2.28%
97,620 $5.4 Million
Q2 2019

Aug 12, 2019

SELL
$49.34 - $63.49 $738,225 - $949,937
-14,962 Reduced 13.03%
99,895 $5.46 Million
Q1 2019

May 13, 2019

SELL
$59.79 - $74.43 $572,489 - $712,667
-9,575 Reduced 7.69%
114,857 $7.27 Million
Q4 2018

Feb 12, 2019

SELL
$65.26 - $85.69 $28,388 - $37,275
-435 Reduced 0.35%
124,432 $8.5 Million
Q3 2018

Nov 09, 2018

SELL
$60.76 - $73.81 $1.32 Million - $1.6 Million
-21,669 Reduced 14.79%
124,867 $9.1 Million
Q2 2018

Aug 14, 2018

SELL
$59.7 - $68.0 $28,297 - $32,232
-474 Reduced 0.32%
146,536 $8.79 Million
Q1 2018

May 11, 2018

SELL
$65.43 - $80.27 $1.49 Million - $1.83 Million
-22,831 Reduced 13.44%
147,010 $9.63 Million
Q4 2017

Feb 13, 2018

SELL
$64.48 - $76.95 $601,985 - $718,405
-9,336 Reduced 5.21%
169,841 $12.3 Million
Q3 2017

Nov 13, 2017

SELL
$77.22 - $82.74 $188,339 - $201,802
-2,439 Reduced 1.34%
179,177 $13.8 Million
Q2 2017

Aug 11, 2017

SELL
N/A
-17,632 Reduced 8.85%
181,616 $14.2 Million
Q2 2017

Aug 10, 2017

BUY
N/A
199,248
199,248 $16.5 Million

Others Institutions Holding WBA

About Walgreens Boots Alliance, Inc.


  • Ticker WBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 864,812,992
  • Market Cap $8.22B
  • Description
  • Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...
More about WBA
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.